Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node evaluation is needed during surgery for non-small cell lung cancer (NSCLC) to ...

Adding immunotherapy to neoadjuvant chemotherapy more than doubled mediastinal lymph node clearance rates compared with ...

Surgery is a common treatment for non-small cell lung cancer (NSCLC), particularly when the disease is detected early and the tumor is small and is only in one part of the lung. For small cell lung ...

Recovery after lung cancer surgery takes time. A lobectomy, a surgery that removes an entire lobe of the lung, is the most common form of lung removal to treat non-small cell lung cancer. These ...

Robotic and video-assisted thoracic surgery have revolutionized lung cancer treatment, minimizing trauma and shortening recovery times. Minimally invasive techniques enable complex procedures, ...

Multidisciplinary evaluation, including thoracic surgical consultation, is crucial for oligometastatic NSCLC patients to optimize treatment strategies. Lung surgery for oligometastatic NSCLC shows ...

Doctors at Main Line Health now have a new kind of robotic surgery that makes recovery quicker and easier for lung cancer patients. Traditional lung cancer surgery usually involves some pain and a ...

Researchers from the University at Buffalo and Roswell Park Comprehensive Cancer Center are developing an artificial ...

Results from a phase 3 clinical trial published in the New England Journal of Medicine, today (June 2nd) show that patients with lung cancer who received an immunotherapy drug, nivolumab, along with ...

Screening guidelines often fail to pinpoint who’s at risk, and few people who are eligible for screening actually get checked ...